About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Takeover Bid of AstraZeneca Given Up by Drugmaker Pfizer

by Himabindu Venkatakrishnan on May 27, 2014 at 11:48 AM
Font : A-A+

 Takeover Bid of AstraZeneca Given Up by Drugmaker Pfizer

Takeover bid of British AstraZeneca was given up by the US drugmaker Pfizer after its final $117-billion offer was rejected last week, the latter said on Monday.

"Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca," the New York-based company said in a statement.

Advertisement

The announcement put an end to a long-running saga that drew widespread attention over fears that British jobs and research capability would be lost and accusations that the tie-up was a cynical ploy by Pfizer to pay less tax.

Pfizer had said that the combined company would deliver an expanded product pipeline, deep potential cost cuts and significant tax savings.

"We continue to believe that our final proposal was compelling and represented full value for AstraZeneca based on the information that was available to us," said Ian Read, chairman and CEO of Pfizer in the statement.
Advertisement

Pfizer's proposal also included a controversial plan to re-domicile the combined company in Britain for tax purposes, in a move that would help it avoid paying billions of dollars in tax to the US government.

Pfizer's play for AstraZeneca comes as global pharmaceutical giants manoeuvre to cope with lost revenues from public sector cutbacks in health care, and patent expirations.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Top Ten Selling Drugs 

Recommended Reading
Pills for Prolonging Life in Lung Cancer Patients
One of the leading causes of deaths in females is lung cancer. Though smoking is the main cause of ....
Merger Tussle Between Drugs Giants Pfizer, AstraZeneca With $100 Bn Deal
An informal approach worth almost $100 billion between US drugs giant Pfizer entering into merger .....
Generic Viagra Sale in US: Pfizer Reaches Settlement With Teva
A patent litigation against Teva Pharmaceuticals over the sale of a generic version of blockbuster ....
Pfizer Plans To Raise Bid for AstraZeneca: Media Reports
Media reports reveal that Pfizer plans to increase its bid to acquire AstraZeneca as it seeks to ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use